124 related articles for article (PubMed ID: 9516833)
1. Alterations of the tumour suppressor gene DCC in neuroblastoma.
Kong XT; Choi SH; Inoue A; Takita J; Yokota J; Hanada R; Yamamoto K; Bessho F; Yanagisawa M; Hayashi Y
Eur J Cancer; 1997 Oct; 33(12):1962-5. PubMed ID: 9516833
[TBL] [Abstract][Full Text] [Related]
2. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
3. Codon 201(Gly) polymorphic type of the DCC gene is related to disseminated neuroblastoma.
Kong XT; Choi SH; Bessho F; Kobayashi M; Hanada R; Yamamoto K; Hayashi Y
Neoplasia; 2001; 3(4):267-72. PubMed ID: 11571626
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
5. Reduced or absent expression and codon 201Gly/Arg polymorphism of DCC gene in rhabdomyosarcoma and Ewing's sarcoma/PNET family.
Choi SH; Kong XT; Taki T; Tsuchida Y; Kawaguchi H; Kato H; Hanada R; Look AT; Hayashi Y
Int J Mol Med; 2000 Oct; 6(4):463-7. PubMed ID: 10998440
[TBL] [Abstract][Full Text] [Related]
6. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues.
Reale MA; Hu G; Zafar AI; Getzenberg RH; Levine SM; Fearon ER
Cancer Res; 1994 Aug; 54(16):4493-501. PubMed ID: 8044801
[TBL] [Abstract][Full Text] [Related]
7. Frequent reduction or loss of DCC gene expression in human osteosarcoma.
Horstmann MA; Pösl M; Scholz RB; Anderegg B; Simon P; Baumgaertl K; Delling G; Kabisch H
Br J Cancer; 1997; 75(9):1309-17. PubMed ID: 9155051
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity at the DCC gene locus is not crucial for the acquisition of metastatic potential in oesophageal squamous cell carcinoma.
Maesawa C; Tamura G; Ogasawara S; Suzuki Y; Sakata K; Sugimura J; Nishizuka S; Sato N; Ishida K; Saito K; Satodate R
Eur J Cancer; 1996 May; 32A(5):896-8. PubMed ID: 9081374
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of heterozygosity at the deleted in colorectal carcinoma gene locus and its association with histologic phenotypes in breast carcinoma.
Kashiwaba M; Tamura G; Ishida M
Virchows Arch; 1995; 426(5):441-6. PubMed ID: 7633654
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer.
Sato K; Tamura G; Tsuchiya T; Endoh Y; Usuba O; Kimura W; Motoyama T
Br J Cancer; 2001 Jul; 85(2):199-203. PubMed ID: 11461076
[TBL] [Abstract][Full Text] [Related]
11. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis.
Miyake S; Nagai K; Yoshino K; Oto M; Endo M; Yuasa Y
Cancer Res; 1994 Jun; 54(11):3007-10. PubMed ID: 8187090
[TBL] [Abstract][Full Text] [Related]
12. Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation.
Schmitt CA; Thaler KR; Wittig BM; Kaulen H; Meyer zum Büschenfelde KH; Dippold WG
Br J Cancer; 1998 Feb; 77(4):588-94. PubMed ID: 9484816
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
Kubo H; Miki C; Kusunoki M
Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the DCC tumor suppressor gene in testicular germ cell tumors: mutations and loss of expression.
Strohmeyer D; Langenhof S; Ackermann R; Hartmann M; Strohmeyer T; Schmidt B
J Urol; 1997 May; 157(5):1973-6. PubMed ID: 9112574
[TBL] [Abstract][Full Text] [Related]
16. Infrequent inactivation of DCC gene in replication error-positive colorectal cancers.
Yamamoto H; Itoh F; Kusano M; Yoshida Y; Hinoda Y; Imai K
Biochem Biophys Res Commun; 1998 Mar; 244(1):204-9. PubMed ID: 9514909
[TBL] [Abstract][Full Text] [Related]
17. Codon 201 polymorphism of DCC gene is a prognostic factor in patients with colorectal cancer.
Zhang H; Arbman G; Sun XF
Cancer Detect Prev; 2003; 27(3):216-21. PubMed ID: 12787729
[TBL] [Abstract][Full Text] [Related]
18. Codon 201Arg/Gly polymorphism of DCC (deleted in colorectal carcinoma) gene in flat- and polypoid-type colorectal tumors.
Minami R; Aoyama N; Honsako Y; Kasuga M; Fujimori T; Maeda S
Dig Dis Sci; 1997 Dec; 42(12):2446-52. PubMed ID: 9440618
[TBL] [Abstract][Full Text] [Related]
19. Mutational state of tumor suppressor genes (DCC, DPC4) and alteration on chromosome 18q21 in human oral cancer.
Watanabe T; Wang X; Miyakawa A; Shiiba M; Imai Y; Sato T; Tanzawa H
Int J Oncol; 1997 Dec; 11(6):1287-90. PubMed ID: 21528336
[TBL] [Abstract][Full Text] [Related]
20. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
Brewster SF; Browne S; Brown KW
J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
